
### [MONDO:0019565](http://purl.obolibrary.org/obo/MONDO_0019565)
**Label:** von willebrand disease

**Subclasses:** [MONDO:0015631](http://purl.obolibrary.org/obo/MONDO_0015631) (von willebrand disease type 2N), [MONDO:0015630](http://purl.obolibrary.org/obo/MONDO_0015630) (von willebrand disease type 2M), [MONDO:0020460](http://purl.obolibrary.org/obo/MONDO_0020460) (acquired von willebrand syndrome), [MONDO:0008332](http://purl.obolibrary.org/obo/MONDO_0008332) (platelet-type bleeding disorder 3), [MONDO:0015628](http://purl.obolibrary.org/obo/MONDO_0015628) (von willebrand disease type 2A), [MONDO:0015629](http://purl.obolibrary.org/obo/MONDO_0015629) (von willebrand disease type 2B), [MONDO:0010756](http://purl.obolibrary.org/obo/MONDO_0010756) (Von Willebrand disease, X-linked form), [MONDO:0008668](http://purl.obolibrary.org/obo/MONDO_0008668) (von willebrand's disease 1), [MONDO:0010191](http://purl.obolibrary.org/obo/MONDO_0010191) (von Willebrand's disease 3), [MONDO:0013304](http://purl.obolibrary.org/obo/MONDO_0013304) (von willebrand's disease 2), 

**Mapped go classes:** [GO:0009897](http://purl.obolibrary.org/obo/GO_0009897) (external side of plasma membrane), [GO:0005178](http://purl.obolibrary.org/obo/GO_0005178) (integrin binding), [GO:0007155](http://purl.obolibrary.org/obo/GO_0007155) (cell adhesion), [GO:0002020](http://purl.obolibrary.org/obo/GO_0002020) (protease binding), [GO:0007596](http://purl.obolibrary.org/obo/GO_0007596) (blood coagulation), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0001890](http://purl.obolibrary.org/obo/GO_0001890) (placenta development), [GO:0005578](http://purl.obolibrary.org/obo/GO_0005578) (proteinaceous extracellular matrix), [GO:0007599](http://purl.obolibrary.org/obo/GO_0007599) (hemostasis), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0001889](http://purl.obolibrary.org/obo/GO_0001889) (liver development), [GO:0051087](http://purl.obolibrary.org/obo/GO_0051087) (chaperone binding), [GO:0031012](http://purl.obolibrary.org/obo/GO_0031012) (extracellular matrix), [GO:0019865](http://purl.obolibrary.org/obo/GO_0019865) (immunoglobulin binding), [GO:0030168](http://purl.obolibrary.org/obo/GO_0030168) (platelet activation), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0042803](http://purl.obolibrary.org/obo/GO_0042803) (protein homodimerization activity), [GO:0033093](http://purl.obolibrary.org/obo/GO_0033093) (Weibel-Palade body), [GO:0051260](http://purl.obolibrary.org/obo/GO_0051260) (protein homooligomerization), [GO:0005783](http://purl.obolibrary.org/obo/GO_0005783) (endoplasmic reticulum), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0005518](http://purl.obolibrary.org/obo/GO_0005518) (collagen binding), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0047485](http://purl.obolibrary.org/obo/GO_0047485) (protein N-terminus binding), [GO:0031589](http://purl.obolibrary.org/obo/GO_0031589) (cell-substrate adhesion), 

**Class expressions from DL-Learner:**

- [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome) 56.25%
- [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space) 56.25%
- Thing 51.81%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) 41.61%
- [GO:0031982](http://purl.obolibrary.org/obo/GO_0031982) (vesicle) and [GO:0043230](http://purl.obolibrary.org/obo/GO_0043230) (extracellular organelle) 41.61%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001221](http://purl.obolibrary.org/obo/GO_2001221) (obsolete positive regulation of G2 phase of mitotic cell cycle)) 41.61%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001220](http://purl.obolibrary.org/obo/GO_2001220) (obsolete negative regulation of G2 phase of mitotic cell cycle)) 41.61%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001219](http://purl.obolibrary.org/obo/GO_2001219) (obsolete positive regulation of S/G2 transition of mitotic cell cycle)) 41.61%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001218](http://purl.obolibrary.org/obo/GO_2001218) (obsolete negative regulation of S/G2 transition of mitotic cell cycle)) 41.61%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001217](http://purl.obolibrary.org/obo/GO_2001217) (obsolete regulation of S/G2 transition of mitotic cell cycle)) 41.61%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001052](http://purl.obolibrary.org/obo/GO_2001052) (null)) 41.61%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001048](http://purl.obolibrary.org/obo/GO_2001048) (null)) 41.61%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001047](http://purl.obolibrary.org/obo/GO_2001047) (null)) 41.61%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001041](http://purl.obolibrary.org/obo/GO_2001041) (null)) 41.61%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2000976](http://purl.obolibrary.org/obo/GO_2000976) (obsolete regulation of transcription from RNA polymerase II promoter involved in detection of glucose)) 41.61%


